chevron_leftBack
As of 24 June 2026, Mahamaya Lifesciences Ltd. has a market cap of $41.34M USD, ranking #31675 globally and #2090 in India.
It ranks #3441 in the Basic Materials sector, and #177 in the Agricultural Inputs industry.
Key Stats
Market Cap
$41.34MUSD
3.92B INR
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.3% | -2.2% | -0.5% | 14% | -8% | 46% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MAHALIFE
ISIN: INE0U9D01019
Shares Out.:
Shares Outstanding:
23.405M1
Shares Float:
6.421M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
169.25 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
|
$6.21B
15K%
588.09B INR
|
2103.2
|
||
NSE: UPL
|
$5.72B
14K%
542.17B INR
|
33.4
|
|
NSE: SUMICHEM
|
$2.3B
5K%
217.83B INR
|
41.0
|
|
NSE: BAYERCROP
|
$2.22B
5K%
210.11B INR
|
31.3
|
|
NSE: TATACHEM
|
$2.18B
5K%
206.21B INR
|
114.6
|
|
NSE: ATUL
|
$2.11B
5K%
200.29B INR
|
29.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSX: NTR
|
$33.77B
82K%
48.0B CAD
|
15.6
|
|
SHE: 000792
|
$30.81B
74K%
209.02B CNY
|
20.3
|
|
NYSE: CF
|
$19.48B
47K%
|
13.6
|
|
TADAWUL: 2020
|
$18.36B
44K%
68.93B SAR
|
15.1
|
|
OSL: YAR
|
$14.08B
34K%
136.53B NOK
|
10.0
|
|
MOEX: PHOR
|
$10.02B
24K%
746.31B RUB
|
8.9
|
chevron_leftBack